Nalaganje...
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
INTRODUCTION: Primary Sjögren’s syndrome (pSS) is an autoimmune disorder affecting exocrine glands; however, a subgroup of pSS patients experience systemic extra-glandular involvement leading to a worsening of disease prognosis. Current therapeutic options are mainly empiric and often translated by...
Shranjeno v:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3979092/ https://ncbi.nlm.nih.gov/pubmed/24286296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4359 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|